Phase I-II Study of Gemcitabine and Fluorouracil as a Continuous Infusion in Patients With Pancreatic Cancer

Manuel Hidalgo(Spanish National Cancer Research Centre), H. Cortés-Funes(Centre Hospitalier René-Dubos), Maite Diaz-Puente(Hospital Universitario 12 De Octubre), Daniel Castellano(Universidad Complutense de Madrid), Cristina Grávalos(Hospital Universitario 12 De Octubre), S. Alonso(Hospital Universitario 12 De Octubre), Luis Paz‐Ares(Universidad Complutense de Madrid), Ricardo Hitt(Research Institute Hospital 12 de Octubre)
Journal of Clinical Oncology
February 1, 1999
10.1200/jco.1999.17.2.585
Cited by 178

Related Papers

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|3.7k
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
|New England Journal of Medicine|2008|3.7k